688197 首藥控股
按盤價 
38.370 +4.260 (+12.489%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -10.609 | -16.662 | -28.777 | -195.939 | -206.150 |
| 總資產報酬率 ROA (%) | -9.611 | -15.391 | -25.610 | -123.473 | -166.958 |
| 投入資產回報率 ROIC (%) | -10.537 | -16.570 | -28.483 | -191.191 | -236.048 | 邊際利潤分析 |
| 銷售毛利率 (%) | 100.000 | 97.871 | 99.371 | 99.932 | 99.941 |
| 營業利潤率 (%) | -2,706.649 | -3,548.333 | -9,518.597 | -1,116.806 | -4,696.104 |
| 息稅前利潤/營業總收入 (%) | -2,822.195 | -3,911.122 | -10,613.206 | -1,122.645 | -4,734.059 |
| 淨利潤/營業總收入 (%) | -2,706.649 | -3,548.792 | -9,512.739 | -1,111.996 | -4,703.466 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.827 | 107.506 | 114.578 | 112.123 | 101.233 |
| 價值變動淨收益/利潤總額(%) | -6.843 | -3.827 | -0.655 | 0.000 | -0.629 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.013 | -0.062 | -0.433 | 0.157 | 償債能力分析 |
| 流動比率 (X) | 7.478 | 10.898 | 13.495 | 0.687 | 7.170 |
| 速動比率 (X) | 7.468 | 10.895 | 13.469 | 0.659 | 7.047 |
| 資產負債率 (%) | 10.703 | 8.197 | 7.137 | 97.419 | 17.072 |
| 帶息債務/全部投入資本 (%) | 0.495 | 0.221 | 0.485 | -3.823 | -- |
| 股東權益/帶息債務 (%) | 20,002.135 | 45,149.973 | 20,485.261 | -803.100 | -1,919.500 |
| 股東權益/負債合計 (%) | 834.350 | 1,119.970 | 1,301.084 | 2.650 | 485.764 |
| 利息保障倍數 (X) | 24.425 | 10.794 | 9.644 | 105.421 | 154.746 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 58.500 | 0.000 | 374.343 | 52.484 | 0.000 |
| 存貨周轉天數 (天) | -- | 4,113.774 | 58,806.566 | 85,920.599 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
